Psoriasis is a common chronic immune-mediated inflammatory skin disorder and begins in
childhood in almost one-third of the cases. Although children present with the same clinical …

Psoriasis is a chronic inflammatory systemic disease associated with an important physical
and physiological burden. It primarily affects the skin, but it is associated with several serious …

Background Crisaborole ointment 2% is a nonsteroidal phosphodiesterase 4 inhibitor for the
treatment of mild-to-moderate atopic dermatitis (AD). The mechanism of action of crisaborole …

Background Psoriasis is an autoimmune and recurrent chronic inflammatory skin disorder
with a strong genetic basis. The characteristic features are hyperproliferation of …

Autoimmune and inflammatory diseases affect innumerous people and are considered a
significant cause of morbidity and mortality worldwide and Curcuma sp can work as …

Psoriasis is a skin disease that is not lethal and does not spread through bodily contact.
However, this seemingly harmless condition can lead to a loss of confidence and social …

Background Atopic dermatitis (AD) presents a large unmet need for treatments with better
safety and efficacy. To facilitate development of topical therapeutics, we need an efficient …

Psoriasis is a chronic inflammatory systemic disease primarily affecting the skin, but which
often involves considerable comorbidities as well. One-third of psoriasis cases start during …

Biologic therapies are increasingly used to treat chronic inflammatory skin diseases such as
psoriasis and atopic dermatitis. In clinical practice, scores based on evaluation of objective …

Background Scalp psoriasis is commonly the initial presentation of psoriasis, and almost
80% of patients with psoriasis will eventually experience it. Objective Although several …